Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
September 12, 2022
Cabaletta Bio Presents New Interim Data from the DesCAARTes™ Phase 1 Trial at the 31st EADV Congress
September 12, 2022
IDEAYA Reports Positive Interim Phase 2 Clinical Results for Darovasertib and Crizotinib Synthetic Lethal Combination in Metastatic Uveal Melanoma
September 9, 2022
Nouscom Strengthens Leadership Team with the Appointments of Sven Gogov, MD, as Chief Medical Officer and Maria Arce-Tomas, PhD, as VP, Head of Regulatory Affairs
September 8, 2022
Purigen Biosystems Expands Commercial Presence in European Union with Proteigene Distribution Agreement
September 6, 2022
Homology Medicines Appoints Albert Seymour, Ph.D., Chief Executive Officer
September 6, 2022
IDEAYA Announces First-Patient-In for Phase I Clinical Trial to Evaluate Darovasertib Monotherapy in (Neo)Adjuvant Uveal Melanoma
September 6, 2022
New Long-Term Safety and Efficacy Data Presented with Paltusotine in Participants Living With Acromegaly
September 2, 2022
South Carolina Department of Corrections and Pear Therapeutics Team Up to Support Inmates in Recovery from Substance Use Disorders
August 29, 2022
Cabaletta Bio to Present Data at the 31st EADV Congress and Provides Update on DesCAARTes™ Trial
August 29, 2022
IDEAYA Announces Achievement of First Milestone in Ongoing Collaboration with GSK for Potential First-in-Class Pol Theta Helicase Inhibitor Development Candidate
« Previous Page
1
…
22
23
24
25
26
…
119
Next Page »